Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...

The World Health Organization is now recommending GLP-1 drugs as a tool to manage obesity in adults. The guidance, which says ...

Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment ...

UW Health's Dr. Jeff Pothof discusses guidance from the World Health Organization and United Nations about the use of certain ...

A new study finds preteens who own smartphones and use them regularly, are at greater risk of depression, obesity and ...

Wegovy maker Novo Nordisk is planning to test its experimental obesity drug, CagriSema, in overweight children and ...

Novo Nordisk A/S is planning a large study of its next-generation obesity shot CagriSema in children, a sign the drugmaker is ...

There are tons of studies that show that what you eat while pregnant can affect your unborn baby, contributing to everything ...

The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.

The COVID-19 pandemic not only disrupted children's education, recreation, and social lives, but it also increased the ...

New longitudinal research shows that Alzheimer’s disease blood biomarkers rise up to 95 percent faster in people with obesity than in those without.

Smartphones are widely owned by children in America, with a Pew Research Center survey finding that 95% of teens ages 13-17 have one, as do nearly 60% of 11- to 12-year-olds and roughly one third of ...